Publication date: Sep 16, 2024
Developing a potent antiviral agent to combat Coronavirus Disease-19 (COVID-19) is of critical importance as we may be at risk of the emergence of new virus strains or another pandemic recurrence. The interaction between the SARS-CoV-2 spike protein and Angiotensin Converting Enzyme 2 (ACE2) is the main protein-protein interaction (PPI) implicated in the virus entry into the host cells. Spike-ACE2 PPI represents a major target for drug intervention. We have repurposed a previously described protein-protein interaction detection method to be utilized as a drug screening assay. The assay was standardized using Chitosan nanoparticles (CNPs) as the drug and SARS-CoV-2 spike-ACE2 interaction as the PPI model. The assay was then used to screen four natural bioactive compounds: Curcumin (Cur), Gallic acid (GA), Quercetin (Q), and Silymarin (Sil), and their cytotoxicity was evaluated in vitro. Production of the spike protein and the evaluation of its activity in comparison to a standard commercial protein was part of our work as well. Here we describe a novel simple immunofluorescent screening assay to identify potential SARS-CoV-2 inhibitors that could assess the inhibitory effect of any ligand against any PPI.
Concepts | Keywords |
---|---|
Coronavirus | ACE2 |
Covid | Immunofluorescent immunoassay |
House | Natural compounds |
Immunofluorescent | Protein-protein interaction |
Nanoparticles | SARS-CoV-2 |
Spike |
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | assay |
disease | IDO | protein |
disease | MESH | Coronavirus Disease-19 |
disease | MESH | recurrence |
disease | IDO | host |
disease | IDO | intervention |
drug | DRUGBANK | Curcumin |
drug | DRUGBANK | Quercetin |
disease | IDO | production |